Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis
NCT03601520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2018-07-27
Summary
This study was designed to test the hypothesis that, irrespective of the degree of interstiaI lung disease and/or pulmonary arterial hypertension, the combined measurement of lung diffusing capacity for nitric oxide and carbon monoxide, might be useful to provide a mechanistic interpretation of changes of diffusion subcomponents in systemic sclerosis (SSc).
Conditions
- Diffusion Limitation of Pulmonary Gas Exchange in Systemic Sclerosis
Sponsors & Collaborators
-
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-01
- Primary Completion
- 2017-10-31
- Completion
- 2017-11-15
More Related Trials
-
Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19
NCT04610554 ·Status: COMPLETED
-
Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD
NCT03438032 ·Status: COMPLETED
-
Airway Inflammation, Symptoms and Lung Function in COPD
NCT01216592 ·Status: COMPLETED
-
Long COVID and Post-exertional Pulmonary Diffusion
NCT05430503 ·Status: COMPLETED
-
A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis
NCT03889509 ·Status: COMPLETED
-
Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic
NCT04441502 ·Status: ACTIVE_NOT_RECRUITING
-
Screening and Multiple Intervention on Lung Epidemics
NCT03654105 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Assessment of Severity and Prognosis in Elderly Patients With COPD and Complex Chronic Comorbidities
NCT01893918 ·Status: UNKNOWN
-
68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis
NCT01321996 ·Status: TERMINATED ·Phase: PHASE4
-
'Real Life' Monitoring of COPD no ICS Patients
NCT05795712 ·Status: COMPLETED
-
Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!
NCT01314807 ·Status: UNKNOWN
-
Hemodynamic Changes in Connective Tissue Disease
NCT01468792 ·Status: COMPLETED
-
Environmental Pollutants in COPD and Lung Cancer
NCT06483490 ·Status: RECRUITING
-
Multiorgan Pathology in Chronic Obstructive Pulmonary Disease (COPD)
NCT00864994 ·Status: UNKNOWN
-
Biomarkers and Genetic Factors Related to Emphysema
NCT00757120 ·Status: COMPLETED
-
Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
NCT01667042 ·Status: COMPLETED
-
Is COPD a Risk Factor for Cardiovascular Disease?
NCT02162095 ·Status: COMPLETED
-
Breath Analysis in Lung Fibrosis
NCT02437448 ·Status: COMPLETED
-
Pathogenetic Mechanisms of Chronic Obstructive Pulmonary Diseases
NCT01378039 ·Status: COMPLETED ·Phase: NA
-
Nonspecific Low Back Pain in Association With Chronic Obstructive Pulmonary Disease
NCT03227523 ·Status: UNKNOWN
-
Clinical & Systems Medicine Investigations of Smoking-related Chronic Obstructive Pulmonary Disease
NCT02627872 ·Status: ACTIVE_NOT_RECRUITING
-
The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease
NCT06652776 ·Status: ENROLLING_BY_INVITATION
-
Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
NCT01460082 ·Status: COMPLETED
-
Influence of Socioeconomic and Environmental Factors on the Natural History of Idiopathic Pulmonary Fibrosis
NCT04619199 ·Status: UNKNOWN ·Phase: NA
-
Small Airways Disease Functional Assessment in Idiopathic Pulmonary Fibrosis (SWIFT-IPF)
NCT07312305 ·Status: RECRUITING